6 Article(s)Download |
PMID | Title | Pub. Year | #Total Relationships |
1 | 34915469 | Crizotinib versus Alectinib for the Treatment of ALK-Positive Non-Small Cell Lung Cancer: A Systematic Review and Meta-Analysis. | 2022 | 1 |
2 | 35155225 | An Insight on the Pathways Involved in Crizotinib and Sunitinib Induced Hepatotoxicity in HepG2 Cells and Animal Model. | 2022 | 1 |
3 | 30642448 | Exploration of germline variants responsible for adverse events of crizotinib in anaplastic lymphoma kinase-positive non-small cell lung cancer by target-gene panel sequencing. | 2019 Feb | 1 |
4 | 26898609 | Crizotinib-induced fatal fulminant liver failure. | 2016 Mar | 1 |
5 | 25239305 | The efficacy and safety of crizotinib in the treatment of anaplastic lymphoma kinase-positive non-small cell lung cancer: a meta-analysis of clinical trials. | 2014 Sep 19 | 1 |
6 | 23386065 | Crizotinib: a new treatment option for ALK-positive non-small cell lung cancer. | 2013 Feb | 1 |